HIV enzymes and processes — Drug Target

All drugs that target HIV enzymes and processes — marketed and clinical-stage. Includes 1 drug classes acting on this target.

Drug classes

Antiretroviral

Marketed (1)

• highly active antiretroviral therapy (HAART) · National Institute of Allergy and Infectious Diseases (NIAID) · Antiretroviral · Immunology
  HAART combines multiple antiretroviral drugs to inhibit different stages of the HIV life cycle, thereby reducing viral replication and improving immune function.